# Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)

> **NCT07013916** · NA · RECRUITING · sponsor: **Queen Mary University of London** · enrollment: 72 (estimated)

## Conditions studied

- MASH - Metabolic Dysfunction-Associated Steatohepatitis
- MASH With Fibrosis
- Steatosis of Liver

## Interventions

- **DIETARY_SUPPLEMENT:** fructose
- **DIETARY_SUPPLEMENT:** glucose

## Key facts

- **NCT ID:** NCT07013916
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07013916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07013916, "Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07013916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*